They quantified circulating CD45-ICAM-1+ tumor cells from 60 HCC patients using flow cytometry and found that higher frequencies of circulating CD45-ICAM-1+ cells in HCC patients correlated with more aggressive tumor behavior and worse clinical outcomes 38. The gene discussed is ICAM1; the disease is neoplasm.